Search Results

Filter
  • 1-10 of  459 results for ""MERKEL cell carcinoma""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

[Retifanlimab in metastatic Merkel cell carcinoma in first line].

  • Authors : Zucman-Rossi C; Service de dermatologie, Gustave-Roussy Cancer Campus, Villejuif, France. Electronic address: .; Boussemart L

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/pathology ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/secondary ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/pathology

  • Source: Bulletin du cancer [Bull Cancer] 2024 Oct; Vol. 111 (10), pp. 906-908. Date of Electronic Publication: 2024 Sep 02.Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck.

  • Authors : Cabezas-Camarero S; Medical Oncology Department, IOB Institute of Oncology-Madrid, Madrid, Spain; Medical Oncology Department, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico Universitario San Carlos, Madrid, Spain. Electronic address: .

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: Oral oncology [Oral Oncol] 2024 Oct; Vol. 157, pp. 106971. Date of Electronic Publication: 2024 Jul 26.Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Magnetic seed localization is feasible for non-palpable melanoma, Merkel cell carcinoma, and soft tissue sarcoma lesions.

  • Authors : van der Burg SJC; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Department of Surgery, Amsterdam, the Netherlands.; Kuijpers A

Subjects: Melanoma*/Melanoma*/Melanoma*/diagnostic imaging ; Melanoma*/Melanoma*/Melanoma*/surgery ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Oct; Vol. 50 Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Merkel cell carcinoma of the eyebrow arch:A case report.

  • Authors : Tang Y; Department of General Surgery, Yellow River Sanmenxia Hospital, Sanmenxia, 472000, China.; Bian C

Subjects: Eyebrows* ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/pathology ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/surgery

  • Source: Asian journal of surgery [Asian J Surg] 2024 Aug; Vol. 47 (8), pp. 3805-3806. Date of Electronic Publication: 2024 May 07.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8900600 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma.

  • Authors : Durand MA; Team 'Biologie des Infections à Polyomavirus', UMR INRAE ISP 1282, University of Tours, Tours, France.; Drouin A

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/immunology ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/pathology ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/genetics

  • Source: The Journal of investigative dermatology [J Invest Dermatol] 2024 Jun; Vol. 144 (6), pp. 1398-1401.e1. Date of Electronic Publication: 2023 Dec 03.Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Merkel cell carcinoma and the eye.

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/therapy ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/diagnosis ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/pathology

  • Source: Clinics in dermatology [Clin Dermatol] 2024 Jul-Aug; Vol. 42 (4), pp. 381-389. Date of Electronic Publication: 2024 Feb 06.Publisher: Elsevier Country of Publication: United States NLM ID: 8406412 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/diagnosis ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/therapy

  • Source: ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 102977. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.

  • Authors : D'Angelo SP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Department of Medicine, Weill Cornell Medical College, New York, USA. Electronic address: .

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103461. Date of Electronic Publication: 2024 May 13.Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study.

  • Authors : de Sousa LG; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu S

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/drug therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy ; Liver Neoplasms*

  • Source: Oral oncology [Oral Oncol] 2024 Apr; Vol. 151, pp. 106747. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Immune checkpoint inhibition therapy as first-line treatment for localized eyelid Merkel cell carcinoma in a nonsurgical candidate.

  • Authors : Zhan S; University of Texas Health Science Center at San Antonio, San Antonio, TX. Electronic address: .; Nguyen M

Subjects: Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/diagnosis ; Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/Carcinoma, Merkel Cell*/drug therapy ; Skin Neoplasms*

  • Source: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Apr; Vol. 59 (2), pp. e183-e184. Date of Electronic Publication: 2023 Nov 22.Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  459 results for ""MERKEL cell carcinoma""